ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 200 filers reported holding ARGENX SE in Q1 2022. The put-call ratio across all filers is 0.51 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $623,000 | +20.0% | 1,645 | 0.0% | 0.01% | +40.0% |
| Q1 2022 | $519,000 | -9.9% | 1,645 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $576,000 | +15.9% | 1,645 | 0.0% | 0.01% | +25.0% |
| Q3 2021 | $497,000 | -94.3% | 1,645 | -94.4% | 0.00% | -93.9% |
| Q2 2021 | $8,789,000 | -40.1% | 29,194 | -45.2% | 0.07% | -40.0% |
| Q1 2021 | $14,682,000 | -10.8% | 53,315 | -4.8% | 0.11% | -14.1% |
| Q4 2020 | $16,466,000 | +7.5% | 55,990 | -4.0% | 0.13% | -12.3% |
| Q3 2020 | $15,318,000 | -34.0% | 58,349 | -43.4% | 0.15% | -39.2% |
| Q2 2020 | $23,214,000 | +34.9% | 103,068 | -21.1% | 0.24% | +6.2% |
| Q1 2020 | $17,212,000 | -17.5% | 130,658 | +0.6% | 0.23% | +22.2% |
| Q4 2019 | $20,855,000 | +48.0% | 129,921 | +5.1% | 0.18% | +31.2% |
| Q3 2019 | $14,091,000 | -19.3% | 123,649 | +0.2% | 0.14% | -16.1% |
| Q2 2019 | $17,467,000 | -10.0% | 123,369 | -20.6% | 0.17% | -8.2% |
| Q1 2019 | $19,400,000 | +13.5% | 155,395 | -12.7% | 0.18% | +2.2% |
| Q4 2018 | $17,093,000 | +29.2% | 177,923 | +2.0% | 0.18% | +61.3% |
| Q3 2018 | $13,230,000 | -12.4% | 174,443 | -4.3% | 0.11% | -20.1% |
| Q2 2018 | $15,107,000 | +7.1% | 182,323 | +4.0% | 0.14% | -1.4% |
| Q1 2018 | $14,105,000 | +6.0% | 175,351 | -16.8% | 0.14% | +4.4% |
| Q4 2017 | $13,305,000 | – | 210,716 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 297,701 | $112,778,070 | 70.21% |
| Artia Global Partners LP | 85,204 | $32,277,831 | 12.30% |
| Avoro Capital Advisors LLC | 1,265,555 | $479,430,201 | 7.16% |
| DCF Advisers, LLC | 25,000 | $9,470,750 | 6.40% |
| Eagle Health Investments LP | 60,300 | $22,843,449 | 5.27% |
| Avidity Partners Management LP | 625,000 | $236,768,750 | 5.13% |
| Bellevue Group AG | 911,100 | $345,152,013 | 4.58% |
| Fairmount Funds Management LLC | 73,526 | $27,853,855 | 4.42% |
| Paradigm Biocapital Advisors LP | 89,556 | $33,926,499 | 3.98% |
| RTW INVESTMENTS, LP | 482,195 | $182,669,932 | 3.73% |